Search Results

There are 1998 results for: content related to: Onabotulinumtoxin A improves urodynamic outcomes in patients with neurogenic detrusor overactivity

  1. The efficacy and safety of onabotulinumtoxinA in treating idiopathic OAB: A systematic review and meta-analysis

    Neurourology and Urodynamics

    Volume 34, Issue 5, June 2015, Pages: 413–419, Yuanshan Cui, Xin Zhou, Huantao Zong, Huilei Yan and Yong Zhang

    Version of Record online : 28 MAR 2014, DOI: 10.1002/nau.22598

  2. Chapter 5: Clinical data in neurogenic detrusor overactivity (NDO) and overactive bladder (OAB)

    Neurourology and Urodynamics

    Volume 33, Issue S3, July 2014, Pages: S26–S31, Francisco Cruz and Victor Nitti

    Version of Record online : 8 JUL 2014, DOI: 10.1002/nau.22630

  3. You have full text access to this OnlineOpen article
    Efficacy and safety of onabotulinumtoxinA therapy are sustained over 4 years of treatment in patients with neurogenic detrusor overactivity: Final results of a long-term extension study

    Neurourology and Urodynamics

    Volume 36, Issue 2, February 2017, Pages: 368–375, Michael Kennelly, Roger Dmochowski, Heinrich Schulte-Baukloh, Karen Ethans, Giulio Del Popolo, Courtenay Moore, Brenda Jenkins, Steven Guard, Yan Zheng, Gilles Karsenty and On Behalf of 191622-094 Investigators

    Version of Record online : 24 NOV 2015, DOI: 10.1002/nau.22934

  4. You have full text access to this OnlineOpen article
    Patient-reported goal achievement following onabotulinumtoxinA treatment in patients with neurogenic detrusor overactivity

    Neurourology and Urodynamics

    Volume 35, Issue 5, June 2016, Pages: 595–600, Emmanuel Chartier-Kastler, Eric Rovner, Zsolt Hepp, Kristin Khalaf, Quanhong Ni and Michael Chancellor

    Version of Record online : 6 APR 2015, DOI: 10.1002/nau.22757

  5. The Therapeutic Effects of Repeated Detrusor Injections Between 200 or 300 Units of OnabotulinumtoxinA in Chronic Spinal Cord Injured Patients

    Neurourology and Urodynamics

    Volume 33, Issue 1, January 2014, Pages: 129–134, Yih-Chou Chen and Hann-Chorng Kuo

    Version of Record online : 12 MAR 2013, DOI: 10.1002/nau.22395

  6. Chapter 6: Practical aspects of administration of onabotulinumtoxinA

    Neurourology and Urodynamics

    Volume 33, Issue S3, July 2014, Pages: S32–S37, Eric Rovner

    Version of Record online : 8 JUL 2014, DOI: 10.1002/nau.22637

  7. You have free access to this content
    Expression of cleaved SNAP-25 after bladder wall injection of onabotulinumtoxina or abobotulinumtoxina: A comparative study in the mice

    Neurourology and Urodynamics

    Volume 36, Issue 1, January 2017, Pages: 86–90, Raquel Oliveira, Ana Coelho, Ana Charrua, António Avelino and Francisco Cruz

    Version of Record online : 16 OCT 2015, DOI: 10.1002/nau.22900

  8. A guideline for the management of bladder dysfunction in Parkinson's disease and other gait disorders

    Neurourology and Urodynamics

    Volume 35, Issue 5, June 2016, Pages: 551–563, Ryuji Sakakibara, Jalesh Panicker, Enrico Finazzi-Agro, Valerio Iacovelli, Homero Bruschini and The Parkinson's Disease Subcomittee, The Neurourology Promotion Committee in The International Continence Society

    Version of Record online : 25 MAR 2015, DOI: 10.1002/nau.22764

  9. Do we understand how botulinum toxin works and have we optimized the way it is administered to the bladder? ICI-RS 2014

    Neurourology and Urodynamics

    Volume 35, Issue 2, February 2016, Pages: 293–298, Apostolos Apostolidis, Mohammad S. Rahnama'i, Christopher Fry, Roger Dmochowski and Arun Sahai

    Version of Record online : 12 FEB 2016, DOI: 10.1002/nau.22797

  10. Adolescence transitional care in neurogenic detrusor overactivity and the use of OnabotulinumtoxinA: A clinical algorithm from an Italian consensus statement

    Neurourology and Urodynamics

    Giovanni Palleschi, Giovanni Mosiello, Valerio Iacovelli, Stefania Musco, Giulio Del Popolo, Antonella Giannantoni, Antonio Carbone, Roberto Carone, Andrea Tubaro, Mario De Gennaro, Antonio Marte and Enrico Finazzi Agrò

    Version of Record online : 6 SEP 2017, DOI: 10.1002/nau.23391

  11. Diabetes mellitus does not affect the efficacy and safety of intravesical onabotulinumtoxina injection in patients with refractory detrusor overactivity

    Neurourology and Urodynamics

    Volume 33, Issue 8, November 2014, Pages: 1235–1239, Chung-Cheng Wang, Chun-Hou Liao and Hann-Chorng Kuo

    Version of Record online : 23 SEP 2013, DOI: 10.1002/nau.22494

  12. Is repeat Botulinum Toxin A injection valuable for neurogenic detrusor overactivity—A systematic review and meta-analysis

    Neurourology and Urodynamics

    Jianshu Ni, Xiaohu Wang, Nailong Cao, Jiemin Si and Baojun Gu

    Version of Record online : 26 JUL 2017, DOI: 10.1002/nau.23354

  13. Can we create a valid treatment algorithm for patients with drug resistant overactive bladder (OAB) syndrome or detrusor overactivity (DO)? Results from a think tank (ICI-RS 2015)

    Neurourology and Urodynamics

    Volume 36, Issue 4, April 2017, Pages: 882–893, Apostolos Apostolidis, Marcio Augusto Averbeck, Arun Sahai, Mohammad Sajjad Rahnama'i, Ralf Anding, Dudley Robinson, Stavros Gravas and Roger Dmochowski

    Version of Record online : 25 APR 2017, DOI: 10.1002/nau.23170

  14. Artificial Urinary Sphincter: Report of the 2015 Consensus Conference

    Neurourology and Urodynamics

    Volume 35, Issue S2, April 2016, Pages: S8–S24, X. Biardeau, S. Aharony, the AUS Consensus Group, L. Campeau and J. Corcos

    Version of Record online : 11 APR 2016, DOI: 10.1002/nau.22989

  15. You have free access to this content
    Predictive factors of adverse events after intravesical suburothelial onabotulinumtoxina injections for overactive bladder syndrome—A real-life practice of 290 cases in a single center

    Neurourology and Urodynamics

    Volume 36, Issue 1, January 2017, Pages: 142–147, Yuan-Hong Jiang, Hueih-Ling Ong and Hann-Chorng Kuo

    Version of Record online : 28 SEP 2015, DOI: 10.1002/nau.22892

  16. Can botox improve night-time overactive bladder symptoms in women?

    Neurourology and Urodynamics

    Volume 36, Issue 3, March 2017, Pages: 648–652, Pawel Miotla, Rufus Cartwright, Konrad Futyma, Michal Bogusiewicz, Katarzyna Skorupska, Izabela Winkler and Tomasz Rechberger

    Version of Record online : 24 FEB 2016, DOI: 10.1002/nau.22983

  17. Reduction of urgency severity is the most important factor in the subjective therapeutic outcome of intravesical onabotulinumtoxinA injection for overactive bladder

    Neurourology and Urodynamics

    Volume 36, Issue 2, February 2017, Pages: 338–343, Yuan-Hong Jiang and Hann-Chorng Kuo

    Version of Record online : 17 NOV 2015, DOI: 10.1002/nau.22925

  18. Chapter 4: Guidelines for the diagnosis and treatment of overactive bladder (OAB) and neurogenic detrusor overactivity (NDO)

    Neurourology and Urodynamics

    Volume 33, Issue S3, July 2014, Pages: S21–S25, Arjun Nambiar and Malcolm Lucas

    Version of Record online : 8 JUL 2014, DOI: 10.1002/nau.22631

  19. Chapter 2: Pathophysiology of neurogenic detrusor overactivity and the symptom complex of “Overactive bladder”

    Neurourology and Urodynamics

    Volume 33, Issue S3, July 2014, Pages: S6–S13, Christopher Chapple

    Version of Record online : 8 JUL 2014, DOI: 10.1002/nau.22635

  20. Different number of intravesical onabotulinumtoxinA injections for patients with refractory detrusor overactivity do not affect treatment outcome: A prospective randomized comparative study

    Neurourology and Urodynamics

    Volume 35, Issue 6, August 2016, Pages: 717–723, Chun-Hou Liao, Sheng-Fu Chen and Hann-Chorng Kuo

    Version of Record online : 24 APR 2015, DOI: 10.1002/nau.22780